Equillium (EQ) to Release Earnings on Thursday

Equillium (NASDAQ:EQ) is anticipated to issue its Q2 2025 quarterly earnings data before the market opens on Thursday, August 14th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter.

Equillium Trading Up 7.0%

Shares of NASDAQ:EQ opened at $0.64 on Thursday. The company has a 50 day moving average of $0.38 and a 200-day moving average of $0.53. The firm has a market cap of $22.77 million, a P/E ratio of -1.63 and a beta of 1.15. Equillium has a twelve month low of $0.27 and a twelve month high of $1.50.

About Equillium

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis.